Healthcare - Medical - Devices - NYSE - US
$ 4.52
11.1 %
$ 169 M
Market Cap
-2.42
P/E
CASH FLOW STATEMENT
-58.8 M
OPERATING CASH FLOW
-7.2 M
INVESTING CASH FLOW
49.5 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Nevro Corp.
| Net Income | -92.2 M |
| Depreciation & Amortization | 11.5 M |
| Capital Expenditures | -8.59 M |
| Stock-Based Compensation | 56.9 M |
| Change in Working Capital | -39.7 M |
| Others | -10.6 M |
| Free Cash Flow | -67.4 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | ||||||||||||
| Net Income | (92.2) | 3.0 | (131.4) | (83.1) | (103.7) | (49.2) | (36.7) | (31.8) | (67.4) | (30.7) | (26.0) | (19.0) |
| Depreciation & Amortization | 11.5 | 10.3 | 8.7 | 8.2 | 7.8 | 3.9 | 2.5 | 1.7 | 0.6 | 96 K | 47 K | 39 K |
| Deferred Income Tax | 0 | 0 | 7.3 | 7.7 | (1.1) | 1.4 | 3.4 | 8.0 | 1.7 | 0.7 | 0 | 0 |
| Stock Based Compensation | 56.9 | 56.8 | 44.4 | 42.7 | 41.7 | 36.6 | 26.1 | 15.8 | 7.3 | 2.0 | 1.6 | 1.1 |
| Other Operating Activities | 4.6 | 3.4 | 13.3 | 14.9 | 7.9 | 7.4 | 10.2 | 10.2 | 1.9 | 1.2 | 1.6 | 0.7 |
| Change in Working Capital | (39.7) | (48.9) | 15.8 | 10.8 | (2.9) | (5.8) | (16.5) | (54.4) | (42.9) | (3.8) | 1.7 | (5.4) |
| Cash From Operations | (58.8) | 24.7 | (41.9) | 1.2 | (50.2) | (5.7) | (14.3) | (58.5) | (100.4) | (31.1) | (21.1) | (22.5) |
| INVESTING CASH FLOW | ||||||||||||
| Capital Expenditures | (8.6) | (7.5) | (12.3) | (6.0) | (3.5) | (8.2) | (4.3) | (3.4) | (5.0) | (0.6) | 55 K | 30 K |
| Other Items | 1.4 | 71.8 | 214.1 | (363.8) | 35.8 | 14.7 | 8.4 | (128.3) | 44.7 | (107.4) | (19.8) | 15.3 |
| Cash From Investing Activities | (7.2) | 64.3 | 201.7 | (369.9) | 32.3 | 6.4 | 4.1 | (131.7) | 39.7 | (108.1) | (19.9) | 15.3 |
| FINANCING CASH FLOW | ||||||||||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 53.6 | 0 | (172.5) | 189.8 | 0 | 0 | 0 | 101.7 | 0 | 19.5 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (10.6) | (8.8) | (8.1) | (32.1) | (3.1) | (1.7) | (1.0) | 43.4 | 0 | 0 | 47.8 | 1.5 |
| Cash From Financing Activities | 49.5 | (2.5) | (169.4) | 346.9 | 32.1 | 7.8 | 11.2 | 145.2 | 122.8 | 152.1 | 47.8 | 1.5 |
| CHANGE IN CASH | ||||||||||||
| Net Change In Cash | (16.2) | 85.7 | (9.9) | (21.1) | 14.5 | 8.2 | 1.4 | (45.6) | 61.7 | 12.9 | 6.8 | (5.7) |
| FREE CASH FLOW | ||||||||||||
| Free Cash Flow | (67.4) | 17.1 | (54.2) | (4.8) | (53.7) | (13.9) | (18.6) | (61.9) | (105.4) | (31.8) | (21.1) | (22.5) |